Literature DB >> 27747882

Gene regulation and genetics in neurochemistry, past to future.

Steven W Barger1,2.   

Abstract

Ask any neuroscientist to name the most profound discoveries in the field in the past 60 years, and at or near the top of the list will be a phenomenon or technique related to genes and their expression. Indeed, our understanding of genetics and gene regulation has ushered in whole new systems of knowledge and new empirical approaches, many of which could not have even been imagined prior to the molecular biology boon of recent decades. Neurochemistry, in the classic sense, intersects with these concepts in the manifestation of neuropeptides, obviously dependent upon the central dogma (the established rules by which DNA sequence is eventually converted into protein primary structure) not only for their conformation but also for their levels and locales of expression. But, expanding these considerations to non-peptide neurotransmitters illustrates how gene regulatory events impact neurochemistry in a much broader sense, extending beyond the neurochemicals that translate electrical signals into chemical ones in the synapse, to also include every aspect of neural development, structure, function, and pathology. From the beginning, the mutability - yet relative stability - of genes and their expression patterns were recognized as potential substrates for some of the most intriguing phenomena in neurobiology - those instances of plasticity required for learning and memory. Near-heretical speculation was offered in the idea that perhaps the very sequence of the genome was altered to encode memories. A fascinating component of the intervening progress includes evidence that the central dogma is not nearly as rigid and consistent as we once thought. And this mutability extends to the potential to manipulate that code for both experimental and clinical purposes. Astonishing progress has been made in the molecular biology of neurochemistry during the 60 years since this journal debuted. Many of the gains in conceptual understanding have been driven by methodological progress, from automated high-throughput sequencing instruments to recombinant-DNA vectors that can convey color-coded genetic modifications in the chromosomes of live adult animals. This review covers the highlights of these advances, both theoretical and technological, along with a brief window into the promising science ahead. This article is part of the 60th Anniversary special issue. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Central Dogma; chromosomal instability; epigenetics; history of medicine; next-gen sequencing; transcription

Mesh:

Substances:

Year:  2016        PMID: 27747882      PMCID: PMC6294479          DOI: 10.1111/jnc.13629

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  388 in total

1.  Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.

Authors:  S Hidaka; H Yoshimatsu; S Kondou; K Oka; Y Tsuruta; H Sakino; E Itateyama; H Noguchi; K Himeno; K Okamoto; Y Teshima; T Okeda; T Sakata
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

2.  Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.

Authors:  Paola Conforti; Chiara Zuccato; Germano Gaudenzi; Alessandro Ieraci; Stefano Camnasio; Noel J Buckley; Cesare Mutti; Franco Cotelli; Alessandro Contini; Elena Cattaneo
Journal:  J Neurochem       Date:  2013-07-19       Impact factor: 5.372

3.  Differential subcellular localization of particular mRNAs in hippocampal neurons in culture.

Authors:  R Kleiman; G Banker; O Steward
Journal:  Neuron       Date:  1990-12       Impact factor: 17.173

4.  DNA content of neurons in the cat hippocampus.

Authors:  C J Herman; L W Lapham
Journal:  Science       Date:  1968-05-03       Impact factor: 47.728

5.  Hypophosphorylation of ribosomal protein S6 is a molecular mechanism underlying ischemic tolerance induced by either hibernation or preconditioning.

Authors:  Shin-ichi Miyake; Hideaki Wakita; Joshua D Bernstock; Paola Castri; Christl Ruetzler; Junko Miyake; Yang-Ja Lee; John M Hallenbeck
Journal:  J Neurochem       Date:  2015-10-22       Impact factor: 5.372

Review 6.  Impaired one carbon metabolism and DNA methylation in alcohol toxicity.

Authors:  Inna I Kruman; Anna-Kate Fowler
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

7.  An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells.

Authors:  A I Geller; M J During; Y J Oh; A Freese; K O'Malley
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

8.  Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2007-03-31       Impact factor: 7.376

9.  Adult neural function requires MeCP2.

Authors:  Christopher M McGraw; Rodney C Samaco; Huda Y Zoghbi
Journal:  Science       Date:  2011-06-02       Impact factor: 47.728

10.  Brown rice and its component, γ-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice.

Authors:  Chisayo Kozuka; Kouichi Yabiku; Sumito Sunagawa; Rei Ueda; Shin-Ichiro Taira; Hiroyuki Ohshiro; Tomomi Ikema; Ken Yamakawa; Moritake Higa; Hideaki Tanaka; Chitoshi Takayama; Masayuki Matsushita; Seiichi Oyadomari; Michio Shimabukuro; Hiroaki Masuzaki
Journal:  Diabetes       Date:  2012-07-23       Impact factor: 9.461

View more
  2 in total

1.  Differential involvement of ipsilateral and contralateral spinal cord astrocyte D-serine in carrageenan-induced mirror-image pain: role of σ1 receptors and astrocyte gap junctions.

Authors:  Hoon-Seong Choi; Dae-Hyun Roh; Seo-Yeon Yoon; Sheu-Ran Choi; Soon-Gu Kwon; Suk-Yun Kang; Ji-Young Moon; Ho-Jae Han; Alvin J Beitz; Jang-Hern Lee
Journal:  Br J Pharmacol       Date:  2018-01-05       Impact factor: 8.739

2.  Genetics of Aggression in Alzheimer's Disease (AD).

Authors:  Walter J Lukiw; Evgeny I Rogaev
Journal:  Front Aging Neurosci       Date:  2017-04-10       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.